Effect of different fatty acids on Neisseria gonorrhoeae viability

Neisseria gonorrhoeae (GC) is the agent of one of the most common bacterial sexually transmitted infections worldwide. The possible development of 'untreatable' infections points out the need for antibiotic-sparing methods to reduce the number of gonococcal infections. In this context, fat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New microbiologica 2021-07, Vol.44 (3), p.164
Hauptverfasser: Morselli, Sara, Valente, Sabrina, Foschi, Claudio, Marangoni, Antonella, Pasquinelli, Gianandrea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Neisseria gonorrhoeae (GC) is the agent of one of the most common bacterial sexually transmitted infections worldwide. The possible development of 'untreatable' infections points out the need for antibiotic-sparing methods to reduce the number of gonococcal infections. In this context, fatty acids are interesting candidates as next-generation antibacterial agents. The aim of this study was to investigate the bactericidal effects of selected fatty acids on GC viability, as well as to observe their biological effects by means of transmission electron microscopy. The cytotoxicity of these compounds on human cervical cells (HeLa), chosen as a model of genital mucosa, was assessed as well. Lauric, myristic, and palmitic acid displayed high killing activity against GC in concentrations ranging between 100 µM and 25 µM, whereas the antimicrobial effect of oleic and butyric acids was present in concentrations between 1 mM and 0.25 mM. Modifications induced by fatty acids on the GC cell included the disorganization of the cytoplasmic structure, the distortion of pili/fimbriae, and the separation of the inner and outer membrane layers. For concentrations active against GC, fatty acids were not toxic for cervical cells. Our data can help in promoting innovative antibiotic-free compounds for the treatment of GC infections.
ISSN:1121-7138